Worldwide, about 35 million people are living with HIV. The World Health Organization and the Joint United Nations Programme on HIV/AIDS plan to use an approach called “treatment as prevention” to eliminate the global pandemic, which the WHO says will have occurred when only one person out of 1,000 becomes infected each year. (more…)
Lightweight, compact device converts an ordinary smartphone into an advanced fluorescence microscope
Fluorescence microscopes use technology that enables them to accomplish tasks not easy to achieve with normal light microscopes, including imaging DNA molecules to detect and diagnose cancer, nervous system disorders such as Alzheimer’s disease, and drug resistance in infectious diseases. (more…)
IBM teams up with Johns Hopkins University and UC San Francisco to help public health officials model, predict and track the possible spread of infectious diseases
SAN JOSE, Calif., – 30 Sep 2013: Scientists from IBM are collaborating with Johns Hopkins University and University of California, San Francisco to combat illness and infectious diseases in real-time with smarter data tools for public health. The focus is to help contain global outbreaks of dengue fever and malaria by applying the latest analytic models, computing technology and mathematical skills on an open-source framework.
Vector-borne diseases, like malaria and dengue fever, are infections transmitted to humans and other animals by blood-feeding insects, such as mosquitoes, ticks and fleas. (more…)
Initial, positive results have been reported for a therapeutic vaccine candidate for treating patients with genital herpes. This first-in-class, investigational, protein subunit vaccine, GEN-003, is under development by Genocea Biosciences Inc.
Dr. Anna Wald, University of Washington professor of medicine and laboratory medicine in the School of Medicine and professor of epidemiology in the School of Public Health, is among those leading clinical studies of GEN-003. The trials are also taking place at six other centers in the United States. (more…)
Knowing the temperatures that viruses, bacteria, worms and all other parasites need to grow and survive could help determine the future range of infectious diseases under climate change, according to new research.
Princeton University researchers developed a model that can identify the prospects for nearly any disease-causing parasite as the Earth grows warmer, even if little is known about the organism. Their method calculates how the projected temperature change for an area would alter the creature’s metabolism and life cycle, the researchers report in the journal Ecology Letters. (more…)
Applications range from protective coating to sterilize hospital surfaces and medical equipment or as an injection to more effectively treat patients
SAN JOSE, Calif. – 24 Jan 2013: Researchers from IBM and the Institute of Bioengineering and Nanotechnology revealed today an antimicrobial hydrogel that can break through diseased biofilms and completely eradicate drug-resistant bacteria upon contact. The synthetic hydrogel, which forms spontaneously when heated to body temperature, is the first-ever to be biodegradable, biocompatible and non-toxic, making it an ideal tool to combat serious health hazards facing hospital workers, visitors and patients.
Traditionally used for disinfecting various surfaces, antimicrobials can be found in traditional household items like alcohol and bleach. However, moving from countertops to treating drug resistant skin infections or infectious diseases in the body are proving to be more challenging as conventional antibiotics become less effective and many household surface disinfectants are not suitable for biological applications. (more…)
New NSF-NIH-USDA-BBSRC grants fund research on how infectious diseases are transmitted
West Nile virus, Lyme disease and hantavirus are all infectious diseases spreading in animals and in people. Is human interaction with the environment somehow responsible for the increase in incidence of these diseases? (more…)
ANN ARBOR, Mich.— A new study of rabies in vampire bats in Peru has found that culling bats—a common rabies control strategy—does not reduce rates of rabies exposure in bat colonies, and may even be counterproductive.
The findings may eventually help public health and agriculture officials in Peru develop more effective methods for preventing rabies infections in humans and livestock, according to a team of scientists from the United States and Peru led by Daniel Streicker, a postdoctoral associate at the University of Georgia Odum School of Ecology.
The study was published online this week in the Proceedings of the Royal Society B. The research team includes University of Michigan population ecologist Pejman Rohani. (more…)
